JPRN-UMIN000026549
Not Yet Recruiting
N/A
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liver - Effect of Dapagliflozin for T2DM with fatty liver
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kagawa prefectural central hospital
- Enrollment
- 25
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •patients with allergy for Dapagliflozin
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Effect of Dapagliflozin in patients with type 2 daibetes mellitusType 2 diabetes mellitusJPRN-UMIN000014922Iwasaki Naika Clinic50
Completed
N/A
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45
Recruiting
Phase 2
A single-site study of the effectiveness of Dapagliflozin for diabetic patients admitted to the intensive care unitDiabetesMetabolic and Endocrine - DiabetesACTRN12621001102864Austin Health40
Not Yet Recruiting
Phase 4
Dapagliflozin in Acute Heart failureIRCT20220529055013N1Public Sector medical University160
Not Yet Recruiting
Phase 4
Assessment of Empagliflozin effects in coronary artery diseaseIRCT20190412043247N2Zanjan University of Medical Sciences100